The Mind's Eye Goes Dark
In the autumn of 2005, a sixty-five-year-old retired building surveyor walked into a memory clinic in Exeter and described something peculiar. Earlier that year, after a minor procedure to image the arteries around his heart, he had suffered a brief amnesic episode, a few hours of confusion typical of transient global amnesia. The confusion lifted, but a quieter loss remained. He could still name the parts of a watch, still rotate a shape in his head to test whether it would fit through a gap, still plan a route from his kitchen to his front door. The pictures behind his eyes, though, were gone. Where the rest of us might close our eyes and watch a slow bloom of colour, MX, as the case report would later call him, saw nothing at all [1].
That paradox, intact spatial thinking with vanished visual imagery, was the spine of the first peer-reviewed case report of what would later be called aphantasia, published in 2010 by the neurologist Adam Zeman, working with Sergio Della Sala and a small team at the University of Edinburgh [1]. They titled the paper "blind imagination" and used fMRI alongside a battery of neuropsychological tests to characterise MX. The simplest reading is that visual mental imagery is one thing, spatial cognition is another, and the brain can lose the first while keeping the second largely intact. The awkward part is that this has always been hard for most people to take in, because we cannot easily step outside our own pictorial minds to picture what their absence might feel like.
Naming the Unseen
For most of the five years between MX's first appointment and 2015, the case sat in a quiet corner of the literature. Then a small observational study gave the pattern its name. Zeman, with Michaela Dewar and Della Sala, recruited twenty-one people who had contacted him after reading about MX in the press. All described a lifelong absence of voluntary visual imagery, and all scored at the floor of the Vividness of Visual Imagery Questionnaire [2]. The team coined two terms. Aphantasia, for the lack of conscious visual imagery, and hyperphantasia, for unusually vivid visual imagery at the other extreme [2].
The 2015 paper drew a careful line. It defined aphantasia as congenital, present from early life rather than acquired after brain injury, and it noted that most of the participants still experienced involuntary images in their dreams. They could not summon a picture of their grandmother on request, but their sleeping minds still produced them. That detail mattered, because it suggested the deficit was not a wholesale failure of the visual brain but something more specific: a missing dial for the deliberate, top-down generation of images [2]. The public reaction was immediate. As Zeman told the BBC at the time, the most frequent thing people said was some version of "I have this too, I thought I was weird" [3].
A Decade of Discovery
What followed was a slow accretion, then a wave. In 2020, Zeman's group returned with a much larger online study using the updated VVIQ-2, and proposed a new umbrella term: phantasia, the capacity to generate mental images, with aphantasia and hyperphantasia marking the extremes of a vividness continuum [4]. That reframe pulled the condition out of the clinic and into a wider individual-differences science. If imagery vividness is a trait, then aphantasia is one end of a distribution rather than a rare pathology to be cured.
The history of noticing the condition goes back much further than Zeman's work, of course. As early as 1880, the polymath Francis Galton had surveyed members of the Royal Society and reported, with some surprise, the following [5]:
"To my astonishment, I found that the great majority of the men of science to whom I first applied, protested that mental imagery was unknown to them."
Galton's observation sat largely unstudied for more than a century. A 2022 prevalence study using the VVIQ painted a more granular contemporary picture: roughly 0.8 per cent of respondents reported no visual imagery at all, while 3.9 per cent described their images as dim or vague [5].
By 2024, Zeman's review in Trends in Cognitive Sciences consolidated a decade of evidence. Aphantasia, he wrote, affects somewhere between two and four per cent of the general population, with hyperphantasia at the other extreme claiming around two and a half per cent [6]. The numbers move depending on the cutoff. That is a debate worth flagging rather than smoothing over.
In 2025, Zeman closed the loop with a decade review in the same journal, Neuropsychologia, that had carried the original MX case fifteen years earlier [7]. A Nature news feature by Elizabeth Quill followed in February 2026, framing aphantasia as a window onto bigger questions [8].
"Aphantasia sits at the crossroads of consciousness, memory and creativity, and is forcing researchers to rethink what mental imagery really is."
Quill's summary captures where the field now sits, somewhere between clinical case report, cognitive trait, and philosophical provocation.
What the Brain Is and Isn't Doing
The behavioural and brain-imaging work has converged on a layered story. Joel Pearson's 2019 review in Nature Reviews Neuroscience argued that visual mental imagery shares many of its neural mechanisms with visual perception, and that individual differences in imagery vividness offer a powerful way to study those shared circuits [9]. One of those circuits runs through the primary visual cortex, V1, the back-of-the-head region that handles the earliest stages of seeing. Transcranial magnetic stimulation work from Pearson's group suggested a kind of mental-strength dial: people with more excitable visual cortices tend to report more vivid imagery, while TMS pulses that briefly disrupt V1 knock down the brightness of imagined scenes. You are, in effect, watching the picture dim as the cortex quiets.
At the other end of the spectrum, work by Dawes, Keogh, Andrillon and Pearson in 2020 showed that aphantasia is not strictly a visual condition. Participants scoring at the bottom of the VVIQ-2 also reported lower vividness in auditory, olfactory and gustatory imagery, a multi-sensory attenuation rather than a vision-only gap [10]. Their dreams, when they remembered them, carried less sensory and emotional intensity than the dreams of strong visualisers. The simplest reading is that aphantasia is the low end of a single trait, phantasia, expressed across the senses rather than confined to one.
The neural signature of vividness is becoming clearer. Work building on Pearson's 2019 synthesis points to the primary visual cortex as a key dial, with imagery strength tied to how strongly the front of the brain can drive activity at the back. Aphantasics and hyperphantasics look, on the limited imaging evidence so far, like opposite settings of the same knob: one end quieter, the other end louder.
Life Without Pictures
For most aphantasics, life is not a deficit so much as a different texture. They tend to report less vivid autobiographical memory, a pattern that overlaps with a related condition called SDAM, or severely deficient autobiographical memory, in which people know facts about their past but cannot re-experience them. Some aphantasics are also face-blind, though the two traits are independent. On the evidence so far, they still think. They still solve problems, still find their way around, still dream, still recognise people they love. The picture that does not form behind the eyes is not, on present evidence, the picture that drives cognition.
What is missing tends to be more felt than measured. Aphantasics often describe a kind of flatness when others speak about mentally rehearsing a scene before a job interview, or picturing a loved one's face when they are away. They can do the task, often by leaning on language, logic, or memory for facts, but they skip the picture that most of us treat as common sense. The simplest reading is that the visual brain is one of several routes into the same thought, and for aphantasics that particular route is dark.
That is the part the research still has to explain. The literature is short on longitudinal data, the self-report instruments carry their own quirks, and the boundary between a vividness extreme and a clinical disorder remains contested. As Zeman's 2025 review and the 2026 Nature feature both note, aphantasia is less a finished diagnosis than a productive question, a small crack through which something larger about the visual brain, and about consciousness itself, has begun to show [7][8].